BioLineRx Ltd. (TLV:BLRX)
2.100
+0.100 (4.76%)
Aug 14, 2025, 5:24 PM IDT
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
2.08M ILS
Profits / Employee
-941.24K ILS
Market Cap
53.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teva Pharmaceutical Industries | 35,686 |
Danel (Adir Yeoshua) | 4,290 |
Kamada | 420 |
Bait Bakfar | 227 |
SofWave Medical | 126 |
BrainsWay | 120 |
Novolog (Pharm-Up 1966) | 936 |
Ilex Medical | 178 |
BioLineRx News
- 11 hours ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 11 hours ago - BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 14 hours ago - Earnings Scheduled For August 14, 2025 - Benzinga
- 1 day ago - BioLineRx Q2 2025 Earnings Preview - Seeking Alpha
- 7 days ago - BioLineRx to Report Second Quarter 2025 Results on August 14, 2025 - PRNewsWire
- 2 months ago - Why Is Nano-Cap BioLineRx Stock Surging On Friday? - Benzinga
- 2 months ago - Why Is Nano-Cap BioLineRx Stock Surging On Friday? - Benzinga
- 2 months ago - BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting - PRNewsWire